Regeneron Pharmaceuticals, Inc.
USD618.95
+16.03 (+2.66%)
CEO
Leonard S. Schleifer
IPO Date
1991-04-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$600.72
Prev. Close
$602.92
Day Low
$599.00
Day High
$623.44
52W Low
$476.49
52W High
$821.11
Market Cap
$63.77B
Volume
0.95M
| 17.4 |
| 31 Dec 2023 | FY | 86.2% | 30.1% | 15.2% | 12.0% | 0.10 | 5.69 | 23.7 |
| 31 Dec 2022 | FY | 87.2% | 35.6% | 19.1% | 14.9% | 0.15 | 5.73 | 18.9 |
| 31 Dec 2021 | FY | 84.8% | 50.2% | 43.0% | 31.7% | 0.18 | 5.95 | 8.8 |
| 31 Dec 2020 | FY | 86.8% | 41.3% | 31.9% | 20.5% | 0.39 | 4.54 | 14.8 |
| 31 Dec 2019 | FY | 90.1% | 26.9% | 19.1% | 14.3% | 0.06 | 5.90 | 19.4 |
| 31 Dec 2018 | FY | 93.5% | 36.4% | 27.9% | 20.8% | 0.07 | 5.89 | 16.5 |
| 31 Dec 2017 | FY | 93.2% | 20.4% | 19.5% | 13.7% | 0.19 | 5.79 | 33.4 |
| 31 Dec 2016 | FY | 93.8% | 18.4% | 20.1% | 12.8% | 0.14 | 3.99 | 42.9 |
| 10.0 |
| 30 Jun 2025 | Q2 | 85.6% | 37.9% | 4.6% | 3.6% | 0.09 | 4.60 | 9.9 |
| 31 Mar 2025 | Q1 | 80.5% | 26.7% | 2.8% | 2.2% | 0.09 | 4.93 | 20.9 |
| 31 Dec 2024 | Q4 | 85.1% | 24.2% | 2.6% | 2.4% | 0.08 | 4.73 | 20.9 |
| 30 Sept 2024 | Q3 | 86.8% | 36.0% | 4.6% | 3.6% | 0.09 | 5.28 | 21.2 |
| 30 Jun 2024 | Q2 | 83.1% | 40.4% | 5.1% | 4.0% | 0.10 | 5.44 | 19.9 |
| 31 Mar 2024 | Q1 | 82.6% | 23.0% | 2.7% | 2.1% | 0.07 | 5.27 | 36.2 |
| 31 Dec 2023 | Q4 | 84.9% | 33.8% | 4.5% | 3.5% | 0.10 | 5.69 | 20.2 |
| 30 Sept 2023 | Q3 | 93.7% | 30.0% | 4.0% | 3.1% | 0.11 | 5.18 | 21.7 |